Literature DB >> 14690552

[Correlation between the expression of collgen IV, VEGF and vasculogenic mimicry].

Xi-shan Hao1, Bao-cun Sun, Shi-wu Zhang, Xiu-lan Zhao.   

Abstract

OBJECTIVE: To study the relationship between collgen (Col) IV, VEGF secreted by the tumor cells and vasculogenic mimicry (VM).
METHODS: 158 bi-phase differential malignant tumor specimens were alloted and made into tissue microarray. These tissue microarray sections were stained with CD31, periodic acid-Schiff (PAS) and Col IV. Subsequently, distributive trait of Col IV and the difference of VEGF expression were analyzed.
RESULTS: The basement membrane of VM was PAS and Col IV positive. The expression of VEGF in bi-phase differential malignant tumor with VM was less than that in those without VM. The difference of VEGF expression in malignant melanoma and alveolar rhabdomyosarcoma was significant (P < 0.05).
CONCLUSION: Collgen IV and periodic acid-Schiff positive material take part in constructing the basement membrane of vasculogenic mimicry. The difference of the VEGF expression proves that vasculogenic mimicry can sustain the tumor blood supply.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14690552

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  8 in total

1.  Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks.

Authors:  Amy Y Lin; Zhuming Ai; Sang-Chul Lee; Peter Bajcsy; Jacob Pe'er; Lu Leach; Andrew J Maniotis; Robert Folberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-03

2.  Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

Authors:  Yue-Zu Fan; Wei Sun
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 3.  Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.

Authors:  Xiaoxu Wei; Yunhua Chen; Xianjie Jiang; Miao Peng; Yiduo Liu; Yongzhen Mo; Daixi Ren; Yuze Hua; Boyao Yu; Yujuan Zhou; Qianjin Liao; Hui Wang; Bo Xiang; Ming Zhou; Xiaoling Li; Guiyuan Li; Yong Li; Wei Xiong; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

4.  Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.

Authors:  Robert Folberg; Zarema Arbieva; Jonas Moses; Amin Hayee; Tone Sandal; Shrihari Kadkol; Amy Y Lin; Klara Valyi-Nagy; Suman Setty; Lu Leach; Patricia Chévez-Barrios; Peter Larsen; Dibyen Majumdar; Jacob Pe'er; Andrew J Maniotis
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

Review 5.  Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside.

Authors:  Parisa Shamshiripour; Fahimeh Hajiahmadi; Shahla Lotfi; Niloofar Robab Esmaeili; Amir Zare; Mahzad Akbarpour; Davoud Ahmadvand
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

6.  Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography.

Authors:  S Frenkel; I Barzel; J Levy; A Y Lin; D-U Bartsch; D Majumdar; R Folberg; J Pe'er
Journal:  Eye (Lond)       Date:  2007-03-16       Impact factor: 3.775

7.  Roxarsone induces angiogenesis via PI3K/Akt signaling.

Authors:  Yujing Wang; Donglai Yin; Chao Xu; Kai Wang; Lingmin Zheng; Yumei Zhang
Journal:  Cell Biosci       Date:  2016-09-28       Impact factor: 7.133

Review 8.  Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.

Authors:  Baocun Sun; Danfang Zhang; Nan Zhao; Xiulan Zhao
Journal:  Oncotarget       Date:  2017-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.